APPLICATION OF FENSPIRIDE IN THE TREATMENT OF CHILDREN WITH ACUTE RESPIRATORY INFECTIONS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Respiratory diseases occupy first place in the structure of morbidity in children, among them the largest proportion belongs to acute respiratory infections (ARI), which have predominantly viral etiology. The pathogenesis of ARI is an inflammation in the mucosal lining caused by the action of various cytokines and mediators. Anti-inflammatory drug fenspiride affects simultaneously on various links of the inflammatory process that has been established in numerous experimental studies. High efficiency and safety of fenspiride in children with ARI has been shown in several comparative clinical studies. The data collected allow to recommend this drug for widespread use in pediatric patients.

全文:

受限制的访问

作者简介

A. Malakhov

SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH

Email: alexis4591m@mail.ru
MD, Prof. of Department of Childhood Illness

N. Geppe

SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH

Department of Childhood Illness

S. Shatalina

SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH

Department of Childhood Illness

I. Dronov

SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH

Department of Childhood Illness

A. Sapunova

MI "Children's City Clinical Hospital №1»

Tver

参考

  1. Российский статистический ежегодник. URL: http://www.gks.ru/bgd/regl/b14_13/IssWWW.exe/Stg/d02/08-33.htm
  2. Комплексный подход к лечению и профилактике острых респираторных инфекций у детей: практическое руководство для врачей / Под ред. Н.А. Геппе, А.Б. Малахова М., 2012. 47 с.
  3. Козлов B.C., Шиленкова В.В., Чистякова О.Д. Роль воспаления в патогенезе респираторных заболеваний. Consilium Medicum. 2003; 10(5): 566-73.
  4. Самсыгина Г.А., Фитилев С.Б., Левин А.М. Результаты многоцентрового исследования эффективности фенспирида гидрохлорида (Эреспал) при лечении острой респираторной инфекции у детей. Педиатрия. 2002; 81(2): 81-5.
  5. Feray J.C., Mohammadi K„ Taouil K., Brunet J., Garay R.P, Hannaert P. Fenspiride and membrane transduction signals in rat alveolar macrophages. Biochem Pharmacol. 1997; 54: 293-97.
  6. Oliveri D., Del Donno М. Efficacy of fenspiride on mucociliary transports. Double-blind with placebo trial. Bull. Eur. Physiopathol. Respir. 1987: (Suppl. 12): 23.
  7. De Castro С.М., Nahori M.F., Dumarey С.Н., Vargaftig B.B., Bachelet M. Fenspiride: an antiinflammatory drug with potential benefits in treatment of endotoxemia. Eur. J. Pharmacol. 1995; 294: 669-76.
  8. Girard V., Naline E., Crambes O., Malbezin M., Malmström R.E., Lundberg J.M., Advenier C. Pre- and postjunctional inhibitory effects of fenspiride on guinea-pig bronchi. Eur. Respir. J. 1997; 10(5): 1015-20.
  9. Evrar Y., Kato G., Bodinier M.C., Chapelain B. Fenspiride et inflamation en pharmacologie experimentale. Eur. Respir. Rev. 1991; 1(2): 33-40.
  10. Jankowski R. ENT inflammation and importance of fenspiride. Presse. Med. 2002; Spec. №1: HS7-10.
  11. Quartulli F., Pinelli E., Broue-Chabbert A., Gossart S., Girard V., Pipy B. Fenspiride inhibits histamine-induced responses in a lung epithelial cell line. Eur. J. Pharmacol. 1998; 348: 297-304.
  12. Cortijo J., Naline E., Ortiz J.L., Berto L., Girard V., Malbezin M., Advenier C., Morcillo E.J. Effects of fenspiride on human bronchial cyclic nucleotide phosphodiesterase isoenzymes: functional and biochemical study. Eur. J. Pharmacol. 1998; 341: 79-86.
  13. Laude Е.А., Bee D., Crambes O., Howard P. Antitussive and antibronchoconstriction actions of fenspirie in guinea-pigs. Eur. Respir. J. 1995; 8: 1699-704.
  14. Khawaja A.M., Liu Y.C., Rogers D.F. Effect of fenspiride, a non-steroidal antiinflammatory agent, on neurogenic mucus secretion in ferret trachea in vitro Pulm. Pharmacol. Ther. 1999; 12: 363-68.
  15. Bee D., Laue E.A., Emery C.J., Howard P. Effect of fenspiride on pulmonary function in the rat and guinea pig. Clin. Sci. (Lond). 1995; 88: 325-30.
  16. Advenier С. Fenspiride and relaxation of tracheobronchial musculature. Mechanism of action. Rhinol. 1988; (Suppl. 4): 67-74.
  17. Lonchampt М., Evrard Y., Duhault J. Recent data on the pharmacology of fenspiride. Rhinol. 1988; (Suppl. 4): 59-66.
  18. De Labarthe B., Gosset X., Dourmap C., Delaval P., Le Rest R. Activity and safety of fenspiride in bronchial hyperexudation. Sem. Hop. 1979; 55: 1549-52.
  19. Геппе Н.А. Применение Эреспала (фенспирида) при острых респираторных заболеваниях у детей: эффективность и безопасность (результаты исследования по программе «Эльф»). Вопр. совр. педиатрии. 2005; 4(2): 53-8.
  20. Самсыгина Г.А. Фенспирид при лечении острой респираторной инфекции у детей раннего возраста. Вопр. совр. педиатрии. 2007; 5: 49-52.
  21. Петрова С.И. Кашель в детском возрасте. Вопр. совр. педиатрии. 2009; 8: 16-23.
  22. Романова Т.А., Сысоева Н.Я., Руднева Е.И., Рубцова Л.В., Восковская Л.Н. Клиническая эффективность препарата эреспал в комплексном лечении острого обструктивного бронхита у детей. Педиатрия. 2013; 92(5).
  23. Zielnik-Jurkiewicz B., Jurkiewicz D. [Usefulness of fenspiride in the treatment of acute otitis media in children]. Pol. Merkur. Lekarski. 2005; 18(108): 624-28.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##